DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,532,592 | +14.4% | 38,422 | +10.7% | 0.06% | +14.0% |
| Q2 2023 | $8,329,429 | +2.9% | 34,706 | +8.0% | 0.05% | -3.8% |
| Q1 2023 | $8,096,971 | +2.0% | 32,126 | +7.4% | 0.05% | -8.8% |
| Q4 2022 | $7,936,793 | +4.5% | 29,903 | +1.6% | 0.06% | -5.0% |
| Q3 2022 | $7,598,000 | -3.5% | 29,418 | -5.3% | 0.06% | -4.8% |
| Q2 2022 | $7,872,000 | +0.1% | 31,052 | +15.8% | 0.06% | +16.7% |
| Q1 2022 | $7,863,000 | -5.3% | 26,806 | +6.2% | 0.05% | -6.9% |
| Q4 2021 | $8,303,000 | +15.0% | 25,237 | +6.4% | 0.06% | -1.7% |
| Q3 2021 | $7,221,000 | +24.7% | 23,720 | +9.9% | 0.06% | +15.7% |
| Q2 2021 | $5,791,000 | +32.2% | 21,580 | +10.9% | 0.05% | +15.9% |
| Q1 2021 | $4,381,000 | +0.4% | 19,463 | -1.0% | 0.04% | -12.0% |
| Q4 2020 | $4,365,000 | -0.6% | 19,652 | -3.6% | 0.05% | -20.6% |
| Q3 2020 | $4,391,000 | +41.9% | 20,391 | +16.5% | 0.06% | +31.2% |
| Q2 2020 | $3,095,000 | +41.7% | 17,500 | +10.9% | 0.05% | -4.0% |
| Q1 2020 | $2,184,000 | -19.3% | 15,780 | -10.5% | 0.05% | -15.3% |
| Q4 2019 | $2,705,000 | +42.1% | 17,622 | +33.7% | 0.06% | +7.3% |
| Q3 2019 | $1,904,000 | +5.5% | 13,180 | +4.4% | 0.06% | +1.9% |
| Q2 2019 | $1,805,000 | +224.1% | 12,628 | +199.2% | 0.05% | +38.5% |
| Q1 2019 | $557,000 | +84.4% | 4,220 | +44.0% | 0.04% | -25.0% |
| Q4 2018 | $302,000 | -46.4% | 2,930 | -43.4% | 0.05% | +67.7% |
| Q3 2018 | $563,000 | +11.0% | 5,179 | +0.9% | 0.03% | -8.8% |
| Q2 2018 | $507,000 | +25.8% | 5,133 | +24.7% | 0.03% | +9.7% |
| Q1 2018 | $403,000 | +0.5% | 4,115 | -4.7% | 0.03% | -11.4% |
| Q4 2017 | $401,000 | +7.8% | 4,317 | -0.5% | 0.04% | 0.0% |
| Q3 2017 | $372,000 | +24.0% | 4,339 | +22.0% | 0.04% | -2.8% |
| Q2 2017 | $300,000 | +6.4% | 3,556 | +7.8% | 0.04% | -30.8% |
| Q1 2017 | $282,000 | – | 3,298 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |